MyChart
Blood and Marrow Transplants, Close to Home
The Blood and Marrow Transplant (BMT) and Hematologic Malignancies program at St. Luke’s Cancer Institute is the first and only one of its kind in Idaho. Our patients receive the region’s most advanced therapies, with the benefit of care close to home.
Studies show that patient outcomes in community transplant programs, such as St. Luke’s Cancer Institute - Center for Blood Cancer Therapy, are equal to those at academic medical centers. Moreover, our patients tell us that their quality of life is better because they’re able to stay close to home and family. We are committed to working with patients and physicians throughout every stage of the transplant process, and to returning patients home as soon as possible.
BMT Program Details
We offer you:
- A highly trained multidisciplinary team of care providers, including specially trained physicians, nurses, social workers, dietitians, and others
- An on-site, full-service BMT lab that performs the collection, cryopreservation, and storage of all stem cell products
- The advantages of participation in national clinical trials and cooperation with regional academic and research centers
- The benefits of a facility accredited by the Foundation for the Accreditation of Cellular Therapy (FACT), a national non-profit organization that promotes high-quality patient care and quality laboratory performance.
Procedure Types
St. Luke's Cancer Institute performs autologous transplants (using the patient’s own stem cells), syngeneic transplants (using cells from an identical twin), and allogeneic transplants (using cells from a matched donor). We also offer chimeric antigen receptor (CAR) T-cell therapy, in which a patient's own T cells are extracted and changed in a lab, the re-infused, enabling the T cells to attack the patient's cancer cells.
Like other recognized centers around the country, our team uses mobilized peripheral blood stem cells in the transplant process (PBSCT). Our facility is a National Marrow Donor Program (NMDP) apheresis center.
Like other recognized centers around the country, our team uses mobilized peripheral blood stem cells in the transplant process (PBSCT). Our facility is a National Marrow Donor Program (NMDP) apheresis center.
Who is a candidate for BMT at St. Luke’s Cancer Institute?
When referred by their oncologist, we treat adult and pediatric patients.
- Autologous transplants for adult patients: lymphomas and Hodgkin’s disease, multiple myeloma, and some testicular cancers
- Autologous transplants for pediatric patients: neuroblastoma, lymphomas, Hodgkin’s disease, medulloblastoma, and germ cell tumors
- Allogeneic transplants for adult patients: acute leukemia, myelodysplastic syndrome, myelofibrosis, certain lymphomas, and other bone marrow cancers
- Chimeric antigen receptor (CAR) T-cell therapy: types of non-Hodgkin’s lymphoma, multiple myeloma and acute lymphoblastic leukemia
Additional Blood and Marrow Transplant Resources
National Cancer Institute
Multiple Myeloma Research Foundation
Multiple Myeloma Research Foundation
Support Groups
-
showing 1 of 1
-
Living Through Cancer Support Group
Support GroupsAn ongoing support program for people with cancer and their loved ones. Share your challenges and discuss topics that influence health and well-being.
Articles & Resources
-
showing 4 of 4
-
Article
The Patient Journey - St. Luke's Cancer Institute
As a cancer patient, it’s important to understand what to expect from your journey, and from the people who will be by your side every step of the way.Read More -
Blog Post
Idaho’s first allogeneic stem cell transplant patient celebrates milestone at St. Luke’s
Read More -
Blog Post
New Pediatric Bone Marrow Transplant Program Keeps Families Closer to Home
Read More -
Blog Post
First in Idaho: St. Luke’s patient receives bone marrow stem cells from unrelated donor
Read More
